A Single-Center Retrospective Cohort Study of Genotype–Phenotype Correlation of Osteogenesis Imperfecta in UAE

Abstract

Background Osteogenesis imperfecta (OI) is a clinically and genetically heterogeneous group of inherited connective tissue disorders characterized by skeletal fragility. Patients with OI suffer recurrent fractures, limb deformities, and kyphoscoliosis. Multiple extraskeletal manifestations might also be present. Autosomal dominant variants in the COL1A1 or COL1A2 genes account for approximately 90% of cases.

Objective The aim of the study was to describe the variant spectrum and genotype–phenotype correlations in patients with OI seen in Tawam Hospital in the UAE.

Methods The authors conducted a retrospective chart review for all patients with OI assessed by geneticists at Tawam Hospital from January 2010 to December 2021. They retrieved each patient's baseline characteristics, detailed history and physical examination, laboratory, imaging, and genetic results.

Results A total of 40 patients with OI were found and included in this study. The majority (80%) were Emirati, and 57.5% were females. Consanguinity was documented in 24.3%. Thirty-seven patients (92.5%) had positive molecular testing; 28 patients (75.7%) had an autosomal dominant inheritance, and 9 patients (24.3%) had an autosomal recessive inheritance. The majority had missense variants. Four variants were novel. A high prevalence of pathogenic variants in the COL1A1 gene (57%) was found. Patients with variants in the LEPRE1 gene had early and severe phenotypes, while patients with variants in the TMEM38B gene had variable presentations. The majority of patients (85%) had skeletal phenotypes: fractures, bone deformity, scoliosis, and osteopenia. Extraskeletal phenotypes included blue sclera, dentinogenesis imperfecta, hearing loss, and dysmorphic features.

Conclusion This study reports the genotype–phenotype correlation of OI patients from the UAE. A high prevalence of pathogenic variants in the COL1A1 gene with OI type IV phenotype was found. Further multicenter more extensive studies are recommended.

Keywords

genotype–phenotype correlation - osteogenesis imperfecta - skeletal phenotypes - extraskeletal phenotypes - OI variants spectrum - UAE

Authors' Contribution

All the authors contributed to the concept and design of the study. A.Q.A.Z. collected data. A.Q.A.Z. and A.A.S. reviewed and analyzed the data, and drafted the manuscript. All the authors contributed to the acquisition of data and revision of the manuscript, and agreed to be accountable for all aspects of the work, ensuring integrity and accuracy.

Ethical Approval

This article does not contain any studies with human participants or animals. This study is approved by the Tawam Human Research Ethics Committee (Ref. No.: AA/AJ/809).

Informed Consent

Written informed consent was obtained during clinical evaluations to proceed with genetic tests.

Publikationsverlauf

Artikel online veröffentlicht:
17. September 2024

• References

• 1 Forlino A, Marini JC. Osteogenesis imperfecta. Lancet 2016; 387 (10028): 1657-1671
• 2 Marini JC, Forlino A, Bächinger HP. et al. Osteogenesis imperfecta. Nat Rev Dis Primers 2017; 3: 17052
• 3 Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 1979; 16 (02) 101-116
• 4 Cho TJ, Lee KE, Lee SK. et al. A single recurrent mutation in the 5′-UTR of IFITM5 causes osteogenesis imperfecta type V. Am J Hum Genet 2012; 91 (02) 343-348
• 5 Unger S, Ferreira CR, Mortier GR. et al. Nosology of genetic skeletal disorders: 2023 revision. Am J Med Genet A 2023; 191 (05) 1164-1209
• 6 Bardai G, Moffatt P, Glorieux FH, Rauch F. DNA sequence analysis in 598 individuals with a clinical diagnosis of osteogenesis imperfecta: diagnostic yield and mutation spectrum. Osteoporos Int 2016; 27 (12) 3607-3613
• 7 Trejo P, Rauch F. Osteogenesis imperfecta in children and adolescents-new developments in diagnosis and treatment. Osteoporos Int 2016; 27 (12) 3427-3437
• 8 Nadyrshina D, Zaripova A, Tyurin A, Minniakhmetov I, Zakharova E, Khusainova R. Osteogenesis imperfecta: search for mutations in patients from the Republic of Bashkortostan (Russia). Genes (Basel) 2022; 13 (01) 12
• 9 Willing MC, Deschenes SP, Scott DA. et al. Osteogenesis imperfecta type I: molecular heterogeneity for COL1A1 null alleles of type I collagen. Am J Hum Genet 1994; 55 (04) 638-647
• 10 Tauer JT, Robinson ME, Rauch F. Osteogenesis imperfecta: new perspectives from clinical and translational research. JBMR Plus 2019; 3 (08) e10174
• 11 Lin X, Hu J, Zhou B. et al. Genotype-phenotype relationship and comparison between eastern and western patients with osteogenesis imperfecta. J Endocrinol Invest 2024; 47 (01) 67-77
• 12 Zhytnik L, Maasalu K, Pashenko A. et al. COL1A1/2 pathogenic variants and phenotype characteristics in Ukrainian osteogenesis imperfecta patients. Front Genet 2019; 10: 722
• 13 Tüysüz B, Elkanova L, Uludağ Alkaya D. et al. Osteogenesis imperfecta in 140 Turkish families: molecular spectrum and, comparison of long-term clinical outcome of those with COL1A1/A2 and biallelic variants. Bone 2022; 155: 116293
• 14 Lin H-Y, Chuang C-K, Su Y-N. et al. Genotype and phenotype analysis of Taiwanese patients with osteogenesis imperfecta. Orphanet J Rare Dis 2015; 10: 152
• 15 Lee K-S, Song H-R, Cho T-J. et al. Mutational spectrum of type I collagen genes in Korean patients with osteogenesis imperfecta. Hum Mutat 2006; 27 (06) 599-599
• 16 Ho Duy B, Zhytnik L, Maasalu K. et al. Mutation analysis of the COL1A1 and COL1A2 genes in Vietnamese patients with osteogenesis imperfecta. Hum Genomics 2016; 10 (01) 27
• 17 Khusainova R, Nadyrshina D, Gilyazova I. et al. Analysis of COL1A1 and COL1A2 genes in osteogenesis imperfecta patients from Russia. Bone 2012; 50: S109
• 18 Lindahl K, Åström E, Rubin CJ. et al. Genetic epidemiology, prevalence, and genotype-phenotype correlations in the Swedish population with osteogenesis imperfecta. Eur J Hum Genet 2015; 23 (08) 1042-1050
• 19 Zhytnik L, Maasalu K, Reimann E, Prans E, Kõks S, Märtson A. Mutational analysis of COL1A1 and COL1A2 genes among Estonian osteogenesis imperfecta patients. Hum Genomics 2017; 11 (01) 19
• 20 Ohata Y, Takeyari S, Nakano Y. et al. Comprehensive genetic analyses using targeted next-generation sequencing and genotype-phenotype correlations in 53 Japanese patients with osteogenesis imperfecta. Osteoporos Int 2019; 30 (11) 2333-2342
• 21 Liu Y, Asan MD, Ma D. et al. Gene mutation spectrum and genotype-phenotype correlation in a cohort of Chinese osteogenesis imperfecta patients revealed by targeted next generation sequencing. Osteoporos Int 2017; 28 (10) 2985-2995
• 22 Alfares A, Alkuraya F. An overview of Mendelian disorders in Saudi Arabia, Riyadh, Saudi Arabia. In: El-Hayek S, Ali MTA, Khaja NA. eds. Genetic Disorders in the Arab World. Dubai: Kingdom of Saudi Arabia; 2016: 26-37
• 23 Essawi O, Symoens S, Fannana M. et al. Genetic analysis of osteogenesis imperfecta in the Palestinian population: molecular screening of 49 affected families. Mol Genet Genomic Med 2018; 6 (01) 15-26
• 24 Saleh S, Beyyumi E, Al Kaabi A. et al. Spectrum of neuro-genetic disorders in the United Arab Emirates national population. Clin Genet 2021; 100 (05) 573-600
• 25 Ben Amor IM, Roughley P, Glorieux FH, Rauch F. Skeletal clinical characteristics of osteogenesis imperfecta caused by haploinsufficiency mutations in COL1A1. J Bone Miner Res 2013; 28 (09) 2001-2007
• 26 Ahmad N, Aleysae NA, Sobaihi M. et al. A single-centre study of genetic mutations, audiology, echocardiogram and pulmonary function in Saudi children with osteogenesis imperfecta. J Pediatr Endocrinol Metab 2021; 35 (03) 355-362